Startseite UR
DFG MA 1982/5-1
 | Eine Stufe nach oben |
Anzahl der Einträge: 5.
Mustroph, Julian 
, Hupf, Julian , Baier, Maria J., Evert, Katja , Brochhausen, Christoph , Broeker, Katharina A. E. , Meindl, Christine , Seither, Benedikt, Jungbauer, Carsten G., Evert, Matthias, Maier, Lars S. und Wagner, Stefan
(2021)
Cardiac Fibrosis Is a Risk Factor for Severe COVID-19.
Frontiers in Immunology 2021 (12), S. 1-13.
Hegner, Philipp, Lebek, Simon, Maier, Lars Siegfried, Arzt, Michael und Wagner, Stefan
(2021)
The Effect of Gender and Sex Hormones on Cardiovascular Disease, Heart Failure, Diabetes, and Atrial Fibrillation in Sleep Apnea.
Frontiers in Physiology 2121 (12), S. 1-8.
Mustroph, Julian , Hupf, Julian, Hanses, Frank, Evert, Katja, Baier, Maria J., Evert, Matthias, Meindl, Christine, Wagner, Stefan, Hubauer, Ute, Pietrzyk, Gabriela, Leininger, Simon, Staudner, Stephan, Vogel, Manuel, Wallner, Stefan, Zimmermann, Markus, Sossalla, Samuel, Maier, Lars S. und Jungbauer, Carsten
(2020)
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19.
ESC Heart Failure 2020, S. 1-8.
Lebek, Simon, Tafelmeier, Maria, Messmann, Rebecca, Provaznik, Zdenek, Schmid, Christof, Maier, Lars S., Birner, Christoph, Arzt, Michael und Wagner, Stefan
(2020)
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
European Journal of Heart Failure 22, S. 2248-2257.
Trum, Maximilian , Riechel, Johannes, Lebek, Simon, Pabel, Steffen, Sossalla, Samuel T., Hirt, Stephan, Arzt, Michael, Maier, Lars S. und Wagner, Stefan
(2020)
Empagliflozin inhibits Na + /H + exchanger activity in human atrial cardiomyocytes.
ESC Heart Failure 2020, S. 1-9.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707